Kala Bio, Inc. (KALA)
Nasdaq: KALA · Pharmaceutical Preparations · Arlington, MA · filing with the SEC since 2009
Filings
353 filings since 2017 beside 312 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Sep 24, 2026.
Filings a yearinsider forms included
3366616078699651
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Aug 28, 2026.Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Feb 20, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Dec 29, 2025.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Oct 1, 2025.SEC letters: 6 in the last 36 months, the newest Feb 13, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
May 7, 2026
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Mar 4, 2026
8-K items 1.01, 3.02, 7.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Mar 3, 2026
Feb 2, 2026
8-K items 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Major agreement signed; Shares sold without registration; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jan 30, 2026
40 of 353 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.